Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed the day trading at $12.00 down -6.18% from the previous closing price of $12.79. In other words, the price has decreased by -$6.18 from its previous closing price. On the day, 0.54 million shares were traded. KALV stock price reached its highest trading level at $12.77 during the session, while it also had its lowest trading level at $11.85.
Ratios:
For a better understanding of KALV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.90 and its Current Ratio is at 9.90. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 15, 2020, initiated with a Buy rating and assigned the stock a target price of $30.
On July 29, 2019, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $31.
On March 20, 2019, Needham started tracking the stock assigning a Buy rating and target price of $35.Needham initiated its Buy rating on March 20, 2019, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 07 ’24 when Palleiko Benjamin L sold 7,465 shares for $11.53 per share. The transaction valued at 86,068 led to the insider holds 224,547 shares of the business.
Feener Edward P. sold 8,088 shares of KALV for $95,151 on May 20 ’24. The CHIEF SCIENTIFIC OFFICER now owns 72,858 shares after completing the transaction at $11.76 per share. On May 20 ’24, another insider, Audhya Paul K., who serves as the CHIEF MEDICAL OFFICER of the company, sold 13,175 shares for $11.76 each. As a result, the insider received 154,997 and left with 70,325 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KALV now has a Market Capitalization of 512827200 and an Enterprise Value of 343504928.
Stock Price History:
Over the past 52 weeks, KALV has reached a high of $16.88, while it has fallen to a 52-week low of $7.21. The 50-Day Moving Average of the stock is -6.89%, while the 200-Day Moving Average is calculated to be 0.61%.
Shares Statistics:
Over the past 3-months, KALV traded about 326.45K shares per day on average, while over the past 10 days, KALV traded about 194980 shares per day. A total of 42.52M shares are outstanding, with a floating share count of 29.44M. Insiders hold about 33.62% of the company’s shares, while institutions hold 84.37% stake in the company. Shares short for KALV as of 1722384000 were 5984017 with a Short Ratio of 18.33, compared to 1719532800 on 5878448. Therefore, it implies a Short% of Shares Outstanding of 5984017 and a Short% of Float of 14.760000000000002.
